COMMUNIQUÉS West-GlobeNewswire

Rgenta Therapeutics Announces RGT-61159 Poster Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
13/10/2026
WOBURN, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for [...]
Envisagenics Awarded $2M+ NCI SBIR Grant to Expand AI-Driven RNA Splicing Analysis Capabilities Across Oncology Portfolio
13/10/2026
Funding will advance translational readiness across Envisagenics’ cancer-specific programs for internal development and strategic partnering NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Envisagenics, Inc. , an AI-driven [...]
TaiMed Biologics to Present Oral and Poster Presentations on TMB-365 and TMB-365/TMB-380 Combination Therapy at IDWeek 2026
13/10/2026
Company will present on a single-dose escalation study of TMB-365 and on resistance in the context of the long-acting TMB-365 and TMB-380 maintenance regimen in people living with HIV TAIPEI, Taiwan, Oct. 13, 2026 ( [...]
The Mindful CRNA Bootcamp Trains Nurses to Handle the Pressure of CRNA School
13/10/2026
Starting October 21, the live program helps nurses build the inner capacity that CRNA school demands. Founder Amanda Kay, MSN, CRNA, will close it with news about the platform's next chapter. CHICAGO, Oct. 13, 2026 ( [...]
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
13/10/2026
Continued Arbli ™ sales growth, combined with REZENOPY ™ commercial launch in August 2026 and initial wholesale shipments, drives significant sequential revenue growth Arbli ™ wholesale unit sales increased 74% [...]
Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP
13/10/2026
October 13, 2026 Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP Update on expected timing of pre-specified futility analysis and database lock Biodexa [...]
DLH Publishes CEO Letter to Shareholders Highlighting “First 100 Days”
13/10/2026
ATLANTA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today [...]
SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi Mantra
13/10/2026
FORT LAUDERDALE, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII) , a developer of innovative surgical robotic technologies [...]
Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference
13/10/2026
CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
13/10/2026
Fast Track designation recognizes the potential of SAB-142 to address an unmet medical need for people with Stage 3 type 1 diabetes MIAMI, Oct. 13, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a [...]
Spectral AI’s DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly
13/10/2026
DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Oorja Bio Announces Initiation of ORBIT-IPF Phase 2 Clinical Trial Evaluating ORJ-001 for the Treatment of Idiopathic Pulmonary Fibrosis
13/10/2026
Randomized, placebo-controlled study to evaluate the safety, tolerability, and efficacy in a robust, two-part study First-in-class therapeutic targets Alveolar Epithelial Type 2 (AEC2) cells with the aim to halt disease [...]
Commure and Compassus Bring AI-Powered Referral Automation to Home-Based Care
13/10/2026
MOUNTAIN VIEW, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Commure, the AI-native enterprise healthcare platform, today announced a strategic partnership with Compassus, a leading national provider of integrated home- [...]
Dianthus Therapeutics Recognized Among Fortune’s 2026 Best Workplaces In BioPharma
13/10/2026
NEW YORK and WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Euclid Vision Corporation Launches My Euclid™, a Cloud-Based Ortho-K Lens Fitting Platform
13/10/2026
My Euclid connects topography-guided lens fitting, ordering, patient management and consultation support in one cloud-based workflow Key facts of this press release: My Euclid is now available, bringing topography- [...]
Long Island Surgeon Launches The Robotic Surgeon, a Podcast That Tells Patients the Truth About Robotic Surgery, Including When They Don't Need It
13/10/2026
Dr. Hesham Atwa of Long Island Laparoscopic Doctors partners with TopHealth on a patient-first podcast and video series built on one promise: no sugarcoating and no selling. EAST SETAUKET, N.Y., Oct. 13, 2026 (GLOBE [...]
ProMom Rebuilds Its Motherhood App Around What Matters Most Right Now
13/10/2026
Based on a woman's stage and what she has shared, the redesigned app shows what to do next and what to know now, with clinically governed guidance and her data kept private San Francisco, CA, Oct. 13, 2026 (GLOBE [...]
VIVUS Lowers Cash Price of QSYMIA® to $75 or Less for a 30-Day Supply
13/10/2026
— Establishes QSYMIA as one of the most affordable branded weight-management options available in the United States — Effective immediately, uniform pricing across all four doses lowers QSYMIA’s annual cost to $780 to $ [...]
23andMe Research Institute Announces Inaugural Scientific Advisory Board
13/10/2026
PALO ALTO, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, today announced the formation of its first Scientific Advisory Board. Composed of leading [...]

Pages